Applied radiation oncology最新文献

{"title":"Radiation-induced Syringomatous Carcinoma: A Case Report","authors":"S. O’Neill, S. Zayed, B. Ahmad","doi":"10.37549/aro1247","DOIUrl":"https://doi.org/10.37549/aro1247","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41440164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Wernicke’s Encephalopathy Secondary to Severe Malnutrition After Definitive Chemoradiation for Oropharyngeal Squamous Cell Carcinoma","authors":"M. Basree, Darrion Mitchell, D. Blakaj, S. Baliga, S. Jhawar, M. Gamez","doi":"10.37549/aro1242","DOIUrl":"https://doi.org/10.37549/aro1242","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44614966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiation Oncologist Perceptions and Utilization of Digital Patient Assessment Platforms.","authors":"P. Zaki, Ganesh Shenoy, J. Gou, Vijay Raj, K. Howell","doi":"10.37549/aro1252","DOIUrl":"https://doi.org/10.37549/aro1252","url":null,"abstract":"Background\u0000Patient engagement is increasing in the presence of digital patient assessment platforms, or physician rating websites. Despite this rapid growth, data remains insufficient regarding how these evaluations impact radiation oncologists.\u0000\u0000\u0000Objectives\u0000The purpose of this study was to assess radiation oncologists worldwide on their awareness and noted effects of digital patient assessment platforms.\u0000\u0000\u0000Methods\u0000An electronic survey was delivered to 6,199 members of the American Society of Radiation Oncology. Subjects were radiation oncologists practicing throughout the world. The survey consisted of 14 questions focused on demographics, practice details, patient volume, institutional utilization of patient reviews, and perceptions of radiation oncologists on health care reviews provided by patients.\u0000\u0000\u0000Results\u0000There were 447 responses from practicing radiation oncologists in total, 321 (72%) of which are in the US. Most respondents (228; 51%) either agreed or strongly agreed that patients consider online reviews when deciding which physician to visit. Of all respondents, 188 (42%) reported that their institution checks their online feedback, whereas 157 (36%) and 99 (22%) respectively reported not knowing, or to their knowledge their institution does not check their online feedback. Respondents who saw more than the average number of consults per week were significantly more likely to receive negative feedback (P = 0.005). Forty-five percent of respondents agreed or strongly agreed that online virtual assessment tools contribute to physician burnout. Respondents (100; 22%) who received inappropriate or misdirected feedback were significantly more likely to report that virtual reviews contribute to burnout (P = 0.001).\u0000\u0000\u0000Conclusions\u0000Radiation oncologists need to be aware that self-reported patient assessments are a data point in the quality of a physician and health care establishment. To best ensure appropriate feedback of a physician's capabilities as a doctor, leadership and employee alignment for patient experience are now more important than ever.","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48785188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiation Recall Dermatitis with Docetaxel and Cyclophosphamide in a Case of Early Stage Breast Cancer Considered High Risk by Molecular Profiling","authors":"John Paul F. Abrina, K. Baldivia","doi":"10.37549/aro1241","DOIUrl":"https://doi.org/10.37549/aro1241","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45396736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiation Oncologist Perceptions and Utilization of Digital Patient Assessment Platforms.","authors":"Peter Zaki,&nbsp;Ganesh Shenoy,&nbsp;Jiangtao Gou,&nbsp;Vijay Raj,&nbsp;Krisha Howell","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Patient engagement is increasing in the presence of digital patient assessment platforms, or physician rating websites. Despite this rapid growth, data remains insufficient regarding how these evaluations impact radiation oncologists.</p><p><strong>Objectives: </strong>The purpose of this study was to assess radiation oncologists worldwide on their awareness and noted effects of digital patient assessment platforms.</p><p><strong>Methods: </strong>An electronic survey was delivered to 6,199 members of the American Society of Radiation Oncology. Subjects were radiation oncologists practicing throughout the world. The survey consisted of 14 questions focused on demographics, practice details, patient volume, institutional utilization of patient reviews, and perceptions of radiation oncologists on health care reviews provided by patients.</p><p><strong>Results: </strong>There were 447 responses from practicing radiation oncologists in total, 321 (72%) of which are in the US. Most respondents (228; 51%) either agreed or strongly agreed that patients consider online reviews when deciding which physician to visit. Of all respondents, 188 (42%) reported that their institution checks their online feedback, whereas 157 (36%) and 99 (22%) respectively reported not knowing, or to their knowledge their institution does not check their online feedback. Respondents who saw more than the average number of consults per week were significantly more likely to receive negative feedback (<i>P</i> = 0.005). Forty-five percent of respondents agreed or strongly agreed that online virtual assessment tools contribute to physician burnout. Respondents (100; 22%) who received inappropriate or misdirected feedback were significantly more likely to report that virtual reviews contribute to burnout (<i>P</i> = 0.001).</p><p><strong>Conclusions: </strong>Radiation oncologists need to be aware that self-reported patient assessments are a data point in the quality of a physician and health care establishment. To best ensure appropriate feedback of a physician's capabilities as a doctor, leadership and employee alignment for patient experience are now more important than ever.</p>","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536100/pdf/nihms-1631422.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38461396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advancing Treatment for Oligometastatic Disease","authors":"J. Suh","doi":"10.37549/aro1244","DOIUrl":"https://doi.org/10.37549/aro1244","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48050442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stereotactic Body Radiation Therapy for Oligometastatic Spine Disease","authors":"M. B. Massat","doi":"10.37549/aro1251","DOIUrl":"https://doi.org/10.37549/aro1251","url":null,"abstract":"30 n APPLIED RADIATION ONCOLOGY www.appliedradiationoncology.com September 2020 O disease (OMD) is an intermediate stage of cancer between an isolated tumor and widespread metastatic disease, where cancer cells from the primary tumor travel through the body/bloodstream to form a small number of clinically detectable metastatic lesions – typically less than 5 – elsewhere in the body. It is a disease state in which therapy may enable longterm disease management, much like with diabetes and heart disease, and unlike prior paradigms where metastatic disease was incurable, treatment may be potentially curative.1","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47004160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcriptional Mechanisms of Radioresistance and Therapeutic Implications","authors":"Daniel Y. Kim, Jimmy A. Guo, Daniel Zhao, E. Philip, Y. R. Li","doi":"10.37549/aro1246","DOIUrl":"https://doi.org/10.37549/aro1246","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48963147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Brachytherapy for Resistant Disseminated Superficial Actinic Porokeratosis","authors":"Josee Smith, S. Narla, A. Lyons, I. Kohli, F. Siddiqui, B. Rao, Lori Penman, I. Hamzavi","doi":"10.37549/aro1250","DOIUrl":"https://doi.org/10.37549/aro1250","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45458990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Oligometastatic Prostate Cancer.","authors":"J. Broughman, C. Fleming, O. Mian, K. Stephans, R. Tendulkar","doi":"10.37549/aro1243","DOIUrl":"https://doi.org/10.37549/aro1243","url":null,"abstract":"Metastatic prostate cancer has long been considered incurable and managed with systemic therapies alone. However, there is increasing evidence of an “oligometastatic” state where patients with low-volume metastatic disease may achieve sustained disease-free intervals as well as potentially improved overall survival (OS) with combinations of systemic and local therapy. The concept of oligometastatic disease was first described by Hellman and Weichselbaum who hypothesized that there may be an intermediate state between locally confined disease and fulminant metastatic disease.1 Accordingly, recent data suggests that aggressive treatment of the primary tumor or metastasis-directed therapy (MDT) may confer a survival advantage in carefully selected patients with metastatic prostate cancer.2-4 Among the 190,000 new cases of prostate cancer diagnosed each year in the US, about 20% present with primary metastatic disease.5,6 Prostate-specific antigen (PSA) screening and imaging advances have led to a relative increase in the detection of cases with early metastatic disease. Even after detection of distant metastases (DM), metastatic prostate cancer is relatively indolent and marked by a long disease course.7 Due to its long natural history, prostate cancer has been at the forefront of efforts investigating aggressive treatment in oligometastatic disease. In this review we aim to outline treatment approaches for these patients, while highlighting existing literature, ongoing trials, and important areas for future study.","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46735474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}